What should be included in the SOAP note for a patient with post-viral cough and mild wheeze?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SOAP Note Documentation for Post-Viral Cough with Mild Wheeze

For a patient presenting with post-viral cough and mild wheeze, document the clinical presentation systematically, assess for red flags requiring further workup, and outline a stepwise treatment approach prioritizing inhaled ipratropium as first-line therapy.

Subjective Section

Document the following specific elements:

  • Duration of cough: Specify if <3 weeks (acute), 3-8 weeks (subacute/post-infectious), or >8 weeks (chronic, requiring reclassification) 1, 2
  • Preceding viral illness: Note recent upper respiratory infection symptoms (nasal congestion, sore throat, fever) 3, 1
  • Cough characteristics: Frequency, productivity, presence of paroxysms, post-tussive vomiting, or inspiratory whooping (suggests pertussis) 1, 2
  • Associated symptoms: Wheeze, breathlessness, chest tightness, fever, fatigue 4, 3
  • Red flag symptoms: Hemoptysis, significant weight loss, voice changes, prolonged fever, night sweats 4, 3, 1
  • Medication history: Specifically document ACE inhibitor use (common cause of persistent cough) 1
  • Smoking history: Current or past use with quantification 1
  • Impact on quality of life: Sleep disruption, work/school absence, severity of distress 2

Objective Section

Include these specific findings:

  • Vital signs: Temperature, respiratory rate (tachypnea >30/min suggests pneumonia), heart rate, oxygen saturation 4
  • Lung examination: Document presence/absence of wheeze, crackles, diminished breath sounds, or normal findings 4
  • General appearance: Signs of respiratory distress, use of accessory muscles 4
  • Additional findings: Presence of nasal discharge, pharyngeal erythema if relevant 3

Do not routinely order chest radiography unless vital signs are abnormal or clinical examination suggests pneumonia 4. Do not routinely measure procalcitonin 4. Consider C-reactive protein only if pneumonia is suspected (CRP >30 mg/L increases likelihood; <10 mg/L makes it unlikely) 4.

Assessment Section

Structure your assessment as follows:

  • Primary diagnosis: Post-viral cough with mild wheeze (if cough duration 3-8 weeks following viral illness) 1, 2
  • Differential considerations documented:
    • Upper airway cough syndrome (33.2% of post-infectious cough cases) 1
    • Cough-variant asthma (15.8% of cases) 1
    • Pertussis if cough ≥2 weeks with paroxysms 1, 2
    • Postviral airway inflammation (48.4% of cases) 1
  • Severity assessment: Mild (normal vital signs, minimal impact) vs. severe (quality of life significantly affected) 2
  • Red flags: Present or absent 3, 1

Plan Section

First-Line Treatment (Document Specific Orders)

  • Inhaled ipratropium bromide: Prescribe as first-line therapy (has demonstrated efficacy in controlled trials for post-infectious cough) 3, 2
  • Honey: Recommend for patients >1 year old (avoid in infants <1 year due to botulism risk) 3
  • Hydration: Advise adequate fluid intake (no more than 2 liters daily) 3
  • Positioning: Avoid lying flat on back 3
  • Symptomatic relief: Dextromethorphan-containing remedies, menthol lozenges 3

Second-Line Treatment (If First-Line Fails)

  • Inhaled corticosteroids: Consider when cough adversely affects quality of life or persists despite ipratropium 3, 2
  • Oral prednisone 30-40 mg daily: For severe paroxysms, short finite period only, after ruling out upper airway cough syndrome, asthma, or GERD 3, 2

For Wheeze Component

  • Bronchodilator therapy: Short-acting beta-agonist (salbutamol/albuterol) as needed for wheeze 5
  • Reassess for asthma: If wheeze persists or recurs, consider trial of inhaled corticosteroids for possible cough-variant asthma 4, 1

What NOT to Do (Document Explicitly)

  • No antibiotics: Unless confirmed bacterial infection (post-viral cough is not bacterial) 3, 2
  • No routine antipyretics: Do not use solely to reduce temperature 3

Follow-Up Plan

  • Routine follow-up in 4-6 weeks 1, 2
  • Reclassify as chronic cough if persists >8 weeks: Requires full chronic cough workup at that point 1, 2
  • Return precautions: Hemoptysis, worsening breathlessness, high fever, symptoms beyond 3 weeks 3

Patient Education (Document Counseling)

  • Expected duration: Post-viral cough typically resolves within 3-8 weeks 1, 2
  • Natural history: 10% of viral coughs last >20-25 days 4
  • When to seek urgent care: Red flag symptoms 3

Common Documentation Pitfalls to Avoid

  • Failing to specify cough duration precisely: This determines classification (acute vs. subacute vs. chronic) and management approach 1, 2
  • Not documenting ACE inhibitor review: A frequently missed reversible cause 1
  • Prescribing antibiotics without bacterial confirmation: Contributes to antimicrobial resistance 3, 2
  • Missing pertussis consideration: Often underdiagnosed in adults with prolonged cough 1, 2

References

Guideline

Assessment of Postinfectious Cough in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Post-Infectious Cough

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Cough from Viral Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.